Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Individualized communications increase colorectal cancer screening completion

Those who received customized messages pertaining to their risk of developing colorectal cancer are 34% more likely to complete the screening than those who are offered standard referrals, research shows.

New data on false positive rates for DBT and DM screenings

Digital breast tomosynthesis exams produce fewer false positive results than standard two-dimensional mammography, though not substantially, experts shared recently in JAMA Open Network.

Radiologists should be mindful of extracolonic findings on CTC scans of cancer patients

Extracolonic findings observed on computed tomography colonography scans of cancer patients might identify undetected malignancies more often than previously thought, according to a new study in Clinical Imaging.

New radiotracer that detects prostate cancer recurrence produces 'stunning' results

The research focused on a radiopharmaceutical that contains the isotope zirconium 89, which has a significantly longer half-life compared to gallium-68-labelled PSMA ligands.

CT-based radiomics nomogram accurately predicts colorectal cancer prognosis

The study's findings could be used to help clinicians guide treatment decisions for CRC patients, experts suggested in Academic Radiology.

FDA approves new radioligand therapy for PSMA positive metastatic prostate cancer

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression.

Research advocates for the return of positive oral contrast in abdominopelvic CT exams

Use of such agents has diminished in recent years, but there is still a great need for oral contrast among oncology patients, experts report in AJR.

These ultrasound features predict ovarian cancer

Doctors created a simple system that categorizes adnexal lesions as classic or nonclassic to streamline the process of ovarian cancer risk stratification.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care